FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302009126> ?p ?o ?g. }

• W4302009126 abstract "Introduction Recent reviews summarize evidence that some vaccines have heterologous or non-specific effects (NSE), potentially offering protection against multiple pathogens. Numerous economic evaluations examine vaccines' pathogen-specific effects, but less than a handful focus on NSE. This paper addresses that gap by reporting economic evaluations of the NSE of oral polio vaccine (OPV) against under-five mortality and COVID-19. Materials and methods We studied two settings: (1) reducing child mortality in a high-mortality setting (Guinea-Bissau) and (2) preventing COVID-19 in India. In the former, the intervention involves three annual campaigns in which children receive OPV incremental to routine immunization. In the latter, a susceptible-exposed-infectious-recovered model was developed to estimate the population benefits of two scenarios, in which OPV would be co-administered alongside COVID-19 vaccines. Incremental cost-effectiveness and benefit-cost ratios were modeled for ranges of intervention effectiveness estimates to supplement the headline numbers and account for heterogeneity and uncertainty. Results For child mortality, headline cost-effectiveness was $650 per child death averted. For COVID-19, assuming OPV had 20% effectiveness, incremental cost per death averted was $23,000–65,000 if it were administered simultaneously with a COVID-19 vaccine &lt;200 days into a wave of the epidemic. If the COVID-19 vaccine availability were delayed, the cost per averted death would decrease to $2600–6100. Estimated benefit-to-cost ratios vary but are consistently high. Discussion Economic evaluation suggests the potential of OPV to efficiently reduce child mortality in high mortality environments. Likewise, within a broad range of assumed effect sizes, OPV (or another vaccine with NSE) could play an economically attractive role against COVID-19 in countries facing COVID-19 vaccine delays. Funding The contribution by DTJ was supported through grants from Trond Mohn Foundation (BFS2019MT02) and Norad (RAF-18/0009) through the Bergen Center for Ethics and Priority Setting." @default.
• W4302009126 created "2022-10-06" @default.
• W4302009126 creator A5002911762 @default.
• W4302009126 creator A5018311050 @default.
• W4302009126 creator A5027955775 @default.
• W4302009126 creator A5028407518 @default.
• W4302009126 creator A5031780095 @default.
• W4302009126 creator A5034897285 @default.
• W4302009126 creator A5043752885 @default.
• W4302009126 creator A5044591266 @default.
• W4302009126 creator A5046124257 @default.
• W4302009126 creator A5063104847 @default.
• W4302009126 creator A5075414157 @default.
• W4302009126 creator A5083188118 @default.
• W4302009126 creator A5083969250 @default.
• W4302009126 date "2022-10-05" @default.
• W4302009126 modified "2023-09-25" @default.
• W4302009126 title "One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19" @default.
• W4302009126 cites W2433021302 @default.
• W4302009126 cites W2529875271 @default.
• W4302009126 cites W2553205120 @default.
• W4302009126 cites W2575734493 @default.
• W4302009126 cites W2618701601 @default.
• W4302009126 cites W2620679745 @default.
• W4302009126 cites W2745104623 @default.
• W4302009126 cites W27566303 @default.
• W4302009126 cites W2853523433 @default.
• W4302009126 cites W2909198830 @default.
• W4302009126 cites W2964102889 @default.
• W4302009126 cites W2996046649 @default.
• W4302009126 cites W3004564833 @default.
• W4302009126 cites W3034512127 @default.
• W4302009126 cites W3046767539 @default.
• W4302009126 cites W3083413691 @default.
• W4302009126 cites W3087218150 @default.
• W4302009126 cites W3091955191 @default.
• W4302009126 cites W3093928668 @default.
• W4302009126 cites W3101305722 @default.
• W4302009126 cites W3106087655 @default.
• W4302009126 cites W3123481858 @default.
• W4302009126 cites W3129715843 @default.
• W4302009126 cites W3131672727 @default.
• W4302009126 cites W3132903079 @default.
• W4302009126 cites W3139533040 @default.
• W4302009126 cites W3162681080 @default.
• W4302009126 cites W3164826098 @default.
• W4302009126 cites W3171220599 @default.
• W4302009126 cites W3217099183 @default.
• W4302009126 cites W4200032842 @default.
• W4302009126 cites W4211212086 @default.
• W4302009126 cites W4220927985 @default.
• W4302009126 cites W4281763895 @default.
• W4302009126 cites W4295885007 @default.
• W4302009126 doi "https://doi.org/10.3389/fpubh.2022.967920" @default.
• W4302009126 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36276367" @default.
• W4302009126 hasPublicationYear "2022" @default.
• W4302009126 type Work @default.
• W4302009126 citedByCount "2" @default.
• W4302009126 countsByYear W43020091262023 @default.
• W4302009126 crossrefType "journal-article" @default.
• W4302009126 hasAuthorship W4302009126A5002911762 @default.
• W4302009126 hasAuthorship W4302009126A5018311050 @default.
• W4302009126 hasAuthorship W4302009126A5027955775 @default.
• W4302009126 hasAuthorship W4302009126A5028407518 @default.
• W4302009126 hasAuthorship W4302009126A5031780095 @default.
• W4302009126 hasAuthorship W4302009126A5034897285 @default.
• W4302009126 hasAuthorship W4302009126A5043752885 @default.
• W4302009126 hasAuthorship W4302009126A5044591266 @default.
• W4302009126 hasAuthorship W4302009126A5046124257 @default.
• W4302009126 hasAuthorship W4302009126A5063104847 @default.
• W4302009126 hasAuthorship W4302009126A5075414157 @default.
• W4302009126 hasAuthorship W4302009126A5083188118 @default.
• W4302009126 hasAuthorship W4302009126A5083969250 @default.
• W4302009126 hasBestOaLocation W43020091261 @default.
• W4302009126 hasConcept C106192422 @default.
• W4302009126 hasConcept C112698675 @default.
• W4302009126 hasConcept C112930515 @default.
• W4302009126 hasConcept C144133560 @default.
• W4302009126 hasConcept C159047783 @default.
• W4302009126 hasConcept C2776811989 @default.
• W4302009126 hasConcept C2778689934 @default.
• W4302009126 hasConcept C2908647359 @default.
• W4302009126 hasConcept C3019080777 @default.
• W4302009126 hasConcept C46299933 @default.
• W4302009126 hasConcept C4870876 @default.
• W4302009126 hasConcept C71924100 @default.
• W4302009126 hasConcept C99454951 @default.
• W4302009126 hasConceptScore W4302009126C106192422 @default.
• W4302009126 hasConceptScore W4302009126C112698675 @default.
• W4302009126 hasConceptScore W4302009126C112930515 @default.
• W4302009126 hasConceptScore W4302009126C144133560 @default.
• W4302009126 hasConceptScore W4302009126C159047783 @default.
• W4302009126 hasConceptScore W4302009126C2776811989 @default.
• W4302009126 hasConceptScore W4302009126C2778689934 @default.
• W4302009126 hasConceptScore W4302009126C2908647359 @default.
• W4302009126 hasConceptScore W4302009126C3019080777 @default.
• W4302009126 hasConceptScore W4302009126C46299933 @default.
• W4302009126 hasConceptScore W4302009126C4870876 @default.
• W4302009126 hasConceptScore W4302009126C71924100 @default.
• W4302009126 hasConceptScore W4302009126C99454951 @default.

• next